SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001523
Filing Date
2017-09-20
Accepted
2017-09-20 16:34:36
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09202017_010926.html 4  
1 form4-09202017_010926.xml 4 4071
  Complete submission text file 0001415889-17-001523.txt   5580
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT 141 ADELAIDE ST. WEST, SUITE 770 TORONTO ONTARIO CANADA M5H 3L5 A6 00000
Business Address
Underdown Brian J. (Reporting) CIK: 0001526335 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 171094299